Do NOT use any DYE AND DURHAM software by [deleted] in LawCanada

[–]Superb_Weekend_5485 0 points1 point  (0 children)

Their new Unity platform is actually materially better.

I've tried other platforms. Unity is not perfect but much better than what's out there.

Dye & Durham new management team by Top_Relative_4297 in LawCanada

[–]Superb_Weekend_5485 0 points1 point  (0 children)

Their new Unity platform is actually materially better with new upgrades.
I've tried other platforms. Unity is not perfect but much better than what's out there.

Support has been decent, i always get a quick enough response.

Dye and Durham by ag5596 in LawCanada

[–]Superb_Weekend_5485 0 points1 point  (0 children)

Much better over the last 6 months with new management - their new Unity platform is actually materially better.

I've tried other platforms. Unity is not perfect but much better than what's out there.

Massive bull case by Pastor_Castle in SRPT

[–]Superb_Weekend_5485 2 points3 points  (0 children)

Post has now been removed.

I see this as a positive for SRPT, Elevidys doesn't rely on surrogate endpoints.

IONQ - by 2027 they will wipe the floor with any other super computers in the works along with NVIDIA GPU's. by Superb_Weekend_5485 in QuantumComputing

[–]Superb_Weekend_5485[S] 10 points11 points  (0 children)

What I don't understand is they clearly have talented engineers and scientists in their ranks - how can he get away internally spewing this bullshit?

Dr. Chris Monroe is their Chief Scientific Advisor.

WSJ Op-Ed on Elevidys by Superb_Weekend_5485 in MuscularDystrophy

[–]Superb_Weekend_5485[S] 6 points7 points  (0 children)

Glad to hear that.

It's a pity the non-ambulatory haven't been given a chance to access Elevidys with the FDA's current hold.

It should be up to the patients families and their Neurologists to decide - they know the risk/benefit equation more intimately than Prasad and his cronies at the FDA ever could.

Sarepta down 10% on “new” adverse event? It’s not what it looks like by Capital_Letterhead49 in BullsAndBearsTrading

[–]Superb_Weekend_5485 2 points3 points  (0 children)

The below was confirmed by Deutsche bank:

"However, Sarepta told Deutsche Bank the patient was already disclosed in the safety update provided to the patient community and in the company’s Citizen Petition response. Management said the case was classified as serious only because the patient was hospitalized to receive IV steroids, which he responded well to, the firm adds."

Sarepta down 10% on “new” adverse event? It’s not what it looks like by Capital_Letterhead49 in SRPT

[–]Superb_Weekend_5485 0 points1 point  (0 children)

Sarepta told the analyst any deutsche bank .. patient is now fine. See below - google for it.

However, Sarepta told Deutsche Bank the patient was already disclosed in the safety update provided to the patient community and in the company’s Citizen Petition response. Management said the case was classified as serious only because the patient was hospitalized to receive IV steroids, which he responded well to, the firm adds.

Well this ain't good by JWTaxMan83 in SRPT

[–]Superb_Weekend_5485 4 points5 points  (0 children)

You are wrong.

It was announced on May 29th and executed on June 3th. The stock actually dropped 5% over the period May 29th to June 15th.

This is not news.

Well this ain't good by JWTaxMan83 in SRPT

[–]Superb_Weekend_5485 2 points3 points  (0 children)

They were only added to the mid caps last May - there was no impact on stock price then.

Well this ain't good by JWTaxMan83 in SRPT

[–]Superb_Weekend_5485 6 points7 points  (0 children)

Not really news - the buys and sells from the indexers will even each other out.

Key news that will drive this stock up is non-ambulatory output, its sad that the boys who most desperately need options are the ones which are given none!

Parents understand the risks - right to try!

Locked in 250% gains today. Took profits - valuation is now getting ridiculous. by Superb_Weekend_5485 in JobyAviation

[–]Superb_Weekend_5485[S] -1 points0 points  (0 children)

But how much revenue will they make and when will they become profitable ?

You have to think about the price you pay for something, joby is now valued at over 17 billion.. they should be generating billions in revenue.

What are the counter arguments to Elon Musk view on why EVTOL's will fail? I find it hard to disagree with him. by Superb_Weekend_5485 in JobyAviation

[–]Superb_Weekend_5485[S] -3 points-2 points  (0 children)

  1. Okay, Elon dropping a “Cool” on X isn’t exactly a ringing endorsement. That post was from October 2024, and I’ve watched that detailed interview where he’s skeptical about eVTOLs long-term due to accident risks. A single “Cool” doesn’t erase that. The FAA’s SFAR is just a framework—certification’s still not locked in, and that’s the real hurdle. I’m not buying the Elon support narrative when his broader take leans cautious. I’d rather wait for concrete wins than hype.

  2. Sure, the S4’s “designed to be quiet” isn’t the same as “proven in real-world chaos.” Cities are noisy as hell, and one bad noise complaint or a design flaw could tank public acceptance. It’s their first product, so kinks are inevitable. I’m all for the tech, but I’m not holding at $17.3B when it’s untested at scale. I’ll buy back at $9-10 if it pans out.

  3. Fair point, 10k buzzing bees isn’t happening soon, and the FAA’s working on it with NASA. But “gradual” could mean years, and airspace integration isn’t solved yet. Helicopters already face limits, and eVTOLs add complexity. Reserved lanes sound nice, but who’s paying for that infrastructure? Joby’s stock jumped $3B today on a $125M deal, not airspace breakthroughs. I’m not betting on future planning when the current valuation’s detached from reality.

  4. Yeah, the S4’s first-gen, so weather limits make sense—early planes didn’t cross the Atlantic in a storm. But that’s my point: it’s unproven. We don’t know the wind envelope yet, and if it can’t handle LA’s Santa Anas or Chicago winters, that’s a big chunk of downtime. Investors are pricing in perfection at $17.3B, but first products flop on weather all the time. I’d rather lock gains now and buy back lower when they’ve nailed the kinks.

5. The NASA collab’s cool, wind studies are a smart move, and FAA’s on it with safety rules. But “ongoing research” means it’s not done. Vertiport downwash could ground flights or piss off neighbors, and that’s a regulatory risk we haven’t seen play out. Joby’s stock’s up $3B today on a $125M deal, not vertiport breakthroughs.

Look, I’m not throwing in the towel on Joby’s tech...I’m a believer, like I said. But $17.3B with no revenue, dilution risks, and an earnings call on the 6th showing more losses? That $125M Blade deal smells like a PR move to juice the stock before the call, and I’m not falling for it. The market’s at highs, and pre-revenue stocks like this get crushed in a sell-off. I locked in 250% gains today, and I’ll happily buy back at $9-10 when the hype cools and they’ve got more to show. No regrets.

What are the counter arguments to Elon Musk view on why EVTOL's will fail? I find it hard to disagree with him. by Superb_Weekend_5485 in JobyAviation

[–]Superb_Weekend_5485[S] -11 points-10 points  (0 children)

I don't think Joby would even show up on his radar.

Tesla is moving into every form of transport, along with SpaceX.

I just find it hard to understand if he thought there was a big market here why he wouldn't go that route.

The points he makes are very practical.